DIAN DIAGNOSTICS(SZ:300244) Xin Lang Cai Jing·2026-01-12 01:54Group 1 - The core point of the news is that Dian Diagnostics experienced a significant stock price increase of 19.15%, reaching 25.88 CNY per share, with a trading volume of 342 million CNY and a turnover rate of 2.72%, resulting in a total market capitalization of 16.174 billion CNY [1] - Dian Diagnostics is based in Hangzhou, Zhejiang Province, and was established on September 5, 2001. It went public on July 19, 2011. The company specializes in providing medical diagnostic services, focusing on outsourcing solutions for various healthcare institutions, including hospitals and health service centers [1] - The revenue composition of Dian Diagnostics consists of 65.34% from channel products and 34.66% from diagnostic services [1] Group 2 - According to data from mutual funds, Wan Jia Fund has a significant holding in Dian Diagnostics, with the Wan Jia Health Industry Mixed A Fund (010054) reducing its holdings by 58,200 shares in the third quarter, now holding 222,000 shares, which represents 5.47% of the fund's net value, making it the seventh-largest holding [2] - The Wan Jia Health Industry Mixed A Fund was established on September 30, 2020, with a latest scale of 56.9046 million CNY. It has achieved a year-to-date return of 20.73%, ranking 5th out of 9,012 in its category, and a one-year return of 22.31%, ranking 5134 out of 8,157 [2]